Gene-Silencing

Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019

Dear friends in the fight against Huntington's disease,

Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic...